LifePoint Health Inc : The mid-term trend could accelerate in few sessions
By Camille Chretien
Entry price | Target | Stop-loss | Potential |
---|---|---|---|
$47.86 | $0 | $45.8 | -100% |
The company is under-valued with an EV/Sales ratio of 1.04x for 2013 (sector : 1.65x).
Following a bullish wave, the stock now shows a slight decline that led it towards the USD 47.3 medium-term support, corresponding to the 100-day moving average. On this level, remobilization of buyer flows would allow an uptrend in the medium and long term.
The USD 47.3 area could be a basis for a purchase to target USD 52. A stop loss will be fixed below USD 47.3.